vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and FINANCIAL INSTITUTIONS INC (FISI). Click either name above to swap in a different company.
FINANCIAL INSTITUTIONS INC is the larger business by last-quarter revenue ($62.7M vs $62.1M, roughly 1.0× Cytek Biosciences, Inc.). FINANCIAL INSTITUTIONS INC runs the higher net margin — 33.5% vs -70.9%, a 104.4% gap on every dollar of revenue. Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs -2.0%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
The Mizuho Financial Group, Inc. , known from 2000 to 2003 as Mizuho Holdings and abbreviated as MHFG or simply Mizuho, is a Japanese banking holding company headquartered in the Ōtemachi district of Chiyoda, Tokyo, Japan. The group was formed in 2000–2002 by merger of Dai-Ichi Kangyo Bank, Fuji Bank, and Industrial Bank of Japan. The name mizuho (瑞穂) literally means "abundant rice" in Japanese and "harvest" in the figurative sense.
CTKB vs FISI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $62.7M |
| Net Profit | $-44.1M | $21.0M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | — |
| Net Margin | -70.9% | 33.5% |
| Revenue YoY | 8.1% | — |
| Net Profit YoY | -557.1% | 24.3% |
| EPS (diluted) | — | $1.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $62.7M | ||
| Q4 25 | $62.1M | $64.1M | ||
| Q3 25 | $52.3M | $63.8M | ||
| Q2 25 | $45.6M | $59.7M | ||
| Q1 25 | $41.5M | $57.2M | ||
| Q4 24 | $57.5M | $41.6M | ||
| Q3 24 | $51.5M | $50.1M | ||
| Q2 24 | $46.6M | $65.2M |
| Q1 26 | — | $21.0M | ||
| Q4 25 | $-44.1M | $20.0M | ||
| Q3 25 | $-5.5M | $20.5M | ||
| Q2 25 | $-5.6M | $17.5M | ||
| Q1 25 | $-11.4M | $16.9M | ||
| Q4 24 | $9.6M | $-82.8M | ||
| Q3 24 | $941.0K | $13.5M | ||
| Q2 24 | $-10.4M | $25.6M |
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | -9.0% | 37.4% | ||
| Q3 25 | -17.6% | 39.5% | ||
| Q2 25 | -23.3% | 36.0% | ||
| Q1 25 | -36.1% | 36.0% | ||
| Q4 24 | 5.2% | -276.9% | ||
| Q3 24 | -8.2% | 29.0% | ||
| Q2 24 | -18.3% | 46.2% |
| Q1 26 | — | 33.5% | ||
| Q4 25 | -70.9% | 38.3% | ||
| Q3 25 | -10.5% | 32.1% | ||
| Q2 25 | -12.2% | 29.3% | ||
| Q1 25 | -27.5% | 29.5% | ||
| Q4 24 | 16.8% | -198.9% | ||
| Q3 24 | 1.8% | 26.9% | ||
| Q2 24 | -22.4% | 39.3% |
| Q1 26 | — | $1.04 | ||
| Q4 25 | — | $0.96 | ||
| Q3 25 | — | $0.99 | ||
| Q2 25 | — | $0.85 | ||
| Q1 25 | — | $0.81 | ||
| Q4 24 | — | $-5.32 | ||
| Q3 24 | — | $0.84 | ||
| Q2 24 | — | $1.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $85.5M |
| Total DebtLower is stronger | — | $114.0M |
| Stockholders' EquityBook value | $341.7M | — |
| Total Assets | $461.5M | $6.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $85.5M | ||
| Q4 25 | $90.9M | $108.8M | ||
| Q3 25 | $93.3M | $185.9M | ||
| Q2 25 | $75.5M | $93.0M | ||
| Q1 25 | $95.3M | $167.4M | ||
| Q4 24 | $98.7M | $87.3M | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — |
| Q1 26 | — | $114.0M | ||
| Q4 25 | — | $193.7M | ||
| Q3 25 | — | $115.0M | ||
| Q2 25 | — | $115.0M | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $124.8M | ||
| Q3 24 | — | $124.8M | ||
| Q2 24 | — | $124.7M |
| Q1 26 | — | — | ||
| Q4 25 | $341.7M | $628.9M | ||
| Q3 25 | $378.6M | $621.7M | ||
| Q2 25 | $377.6M | $601.7M | ||
| Q1 25 | $379.6M | $589.9M | ||
| Q4 24 | $395.7M | $569.0M | ||
| Q3 24 | $385.5M | $500.3M | ||
| Q2 24 | $389.1M | $467.7M |
| Q1 26 | — | $6.3B | ||
| Q4 25 | $461.5M | $6.3B | ||
| Q3 25 | $494.9M | $6.3B | ||
| Q2 25 | $493.3M | $6.1B | ||
| Q1 25 | $482.6M | $6.3B | ||
| Q4 24 | $499.5M | $6.1B | ||
| Q3 24 | $491.2M | $6.2B | ||
| Q2 24 | $483.7M | $6.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.31× | ||
| Q3 25 | — | 0.18× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.21× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.25× | ||
| Q2 24 | — | 0.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | — |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -2.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-771.0K | $18.8M | ||
| Q3 25 | $-3.9M | $-6.9M | ||
| Q2 25 | $108.0K | $-5.7M | ||
| Q1 25 | $-125.0K | $10.0M | ||
| Q4 24 | $2.0M | $77.1M | ||
| Q3 24 | $13.2M | $2.1M | ||
| Q2 24 | $6.2M | $35.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-1.8M | $13.3M | ||
| Q3 25 | $-4.6M | $-7.9M | ||
| Q2 25 | $-1.5M | $-7.3M | ||
| Q1 25 | $-974.0K | $9.2M | ||
| Q4 24 | $1.1M | $72.2M | ||
| Q3 24 | $12.2M | $-299.0K | ||
| Q2 24 | $5.2M | $34.7M |
| Q1 26 | — | — | ||
| Q4 25 | -2.9% | 20.7% | ||
| Q3 25 | -8.7% | -12.4% | ||
| Q2 25 | -3.2% | -12.3% | ||
| Q1 25 | -2.3% | 16.1% | ||
| Q4 24 | 1.9% | 173.3% | ||
| Q3 24 | 23.7% | -0.6% | ||
| Q2 24 | 11.0% | 53.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 8.7% | ||
| Q3 25 | 1.3% | 1.6% | ||
| Q2 25 | 3.5% | 2.7% | ||
| Q1 25 | 2.0% | 1.4% | ||
| Q4 24 | 1.6% | 11.9% | ||
| Q3 24 | 2.0% | 4.9% | ||
| Q2 24 | 2.3% | 1.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.94× | ||
| Q3 25 | — | -0.34× | ||
| Q2 25 | — | -0.33× | ||
| Q1 25 | — | 0.59× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | 0.16× | ||
| Q2 24 | — | 1.39× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
FISI
| Net Interest Income | $52.0M | 83% |
| Noninterest Income | $10.7M | 17% |
